Copyright
©The Author(s) 2022.
World J Cardiol. Oct 26, 2022; 14(10): 537-545
Published online Oct 26, 2022. doi: 10.4330/wjc.v14.i10.537
Published online Oct 26, 2022. doi: 10.4330/wjc.v14.i10.537
Figure 1 STROBE diagram showing flow of patients in the study.
ACEi: Angiotensin converting enzyme inhibitor; ARB: Angiotensin receptor blocker; AA: Atrial arrhythmia.
Figure 2 One-year Kaplan–Meier Survival curve of atrial arrythmia recurrence after cryoablation by angiotensin-converting enzyme inhibitors / angiotensin receptor blockers use.
AA: Atrial arrhythmia; ACEi: Angiotensin converting enzyme inhibitor; ARB: Angiotensin receptor blocker.
- Citation: Al-Seykal I, Bose A, Chevli PA, Hashmath Z, Sharma N, Mishra AK, Laidlaw D. Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation. World J Cardiol 2022; 14(10): 537-545
- URL: https://www.wjgnet.com/1949-8462/full/v14/i10/537.htm
- DOI: https://dx.doi.org/10.4330/wjc.v14.i10.537